These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24867895)

  • 1. Botulinum toxin type A and myofascial pain syndrome: a retrospective study of 301 patients.
    Avendaño-Coy J; Gómez-Soriano J; Valencia M; Estrada J; Leal F; Ruiz-Campa R
    J Back Musculoskelet Rehabil; 2014; 27(4):485-92. PubMed ID: 24867895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of myofascial pain syndrome (MPS) with botulinum toxin type A (BoNT-A)].
    Günther O; Bitterlich N
    MMW Fortschr Med; 2011 Jul; 153 Suppl 2():64-9. PubMed ID: 23964470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
    Desai MJ; Shkolnikova T; Nava A; Inwald D
    Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY; Wang D
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis.
    Ahmed S; Subramaniam S; Sidhu K; Khattab S; Singh D; Babineau J; Kumbhare DA
    Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials.
    Leonardi G; Alito A; Portaro S; Di Matteo B; Respizzi S; Kon E; Massazza G; Sconza C
    Eur J Pain; 2024 Mar; 28(3):369-381. PubMed ID: 37950343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS; Nolan PJ
    J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
    De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
    Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
    Adelowo A; Hacker MR; Shapiro A; Modest AM; Elkadry E
    Female Pelvic Med Reconstr Surg; 2013; 19(5):288-92. PubMed ID: 23982578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.